Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Doctri-Cee Max - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Doctri-Cee Max

Approved

STANDARD

Doctri-Cee Max

Theramedic Laboratories Corp.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: dc6e118da9f25d3b
Company: Theramedic Laboratories Corp.
Type: Standard

Approval Details

Approval Id: dc6e118da9f25d3b
Drug Approval Philippines Name: Doctri-Cee Max
Product Name: Doctri-Cee Max
Registration Number: DR-XY48048
Brand Name: Doctri-Cee Max
Generic Name: Ascorbic Acid + Zinc + Colecalciferol (Vitamin D3)
Dosage Form: Capsule
Dosage Strength: 533.40mg (equivalent to 600mg Sodium Ascorbate) / 5 mg (equivalent to 13.725mg Zinc Sulfate Monohydrate) / 1000 IU
Manufacturer: Theramedic Laboratories Corp.
Distributor: RRAF Marketing Corp.
Issuance Date: 31 May 2022
Expiry Date: 31 May 2027
Pharmacologic Category: Vitamin / Mineral
Classification: Over-the-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

dc6e118da9f25d3b

Type

Standard

Back to Philippines FDA Approvals